Hearst invests $75 million in Moffitt's M2Gen

M2Gen, a Moffitt Cancer Center subsidiary that uses big data to find ways to treat cancer, is receiving a $75 million equity investment from Hearst. The partnership will help accelerate the discovery of innovative cancer therapies and improve care for patients nationwide, Hearst said in a press release. The press release did not disclose the amount of the investment, but a Moffitt spokeswoman confirmed it was $75 million. Hearst invests in c ompanies working to improve and advance health care,…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news